DFDA

Radical Inguinal Orchiectomy

Treatment for Testicular Cancer

Typical Dosage: Surgical procedure

Effectiveness
98%
Safety Score
70%
Clinical Trials
1
Participants
1M

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Surgical procedure
Time to Effect
Immediate (tumor removal)
Treatment Duration
Single procedure
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$3,000
Side Effect Mgmt:$500
Total Annual:$13,700
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$10,000/QALY
QALYs Gained
25
Outcome-Based Costs
Cost per Remission
$16,118
Radical Inguinal Orchiectomy Outcomes

for Testicular Cancer

Efficacy Outcomes
Overall Effectiveness
+98%
Response Rate
+100%
Remission Rate
+85%
Common Side Effects
Post-operative pain
+80%
Scrotal swelling/hematoma
+10%
Wound infection
+3%
Nerve damage/numbness
+1%

Sources:

nih.gov
cancer.org
amegroups.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Radical Inguinal Orchiectomy in Testicular Cancer

Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy

NCT06828185RECRUITINGNA
View Study
80 participants
INTERVENTIONAL
Loma Linda, United States
Started: Dec 1, 2025